Johnson & Johnson Approaches Actelion About Potential Deal – Wall Street Journal

Johnson & Johnson Approaches Actelion About Potential Deal
Wall Street Journal
Johnson & Johnson said Friday it is in “preliminary discussions” with Swiss drug company Actelion Pharmaceuticals Ltd., a deal that would help the health-products company overcome any lost momentum for its top-selling drug. J&J, which is based in New …
Breaking Down Resistance to a Drug DealBloomberg
Jamp;J (JNJ) Reportedly Approaches Actelion for AcquisitionZacks.com
Johnson & Johnson in talks to acquire ActelionBusiness Standard
New York Times –MarketWatch –USA TODAY –Fortune
all 136 news articles »